JP2006525980A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525980A5
JP2006525980A5 JP2006506051A JP2006506051A JP2006525980A5 JP 2006525980 A5 JP2006525980 A5 JP 2006525980A5 JP 2006506051 A JP2006506051 A JP 2006506051A JP 2006506051 A JP2006506051 A JP 2006506051A JP 2006525980 A5 JP2006525980 A5 JP 2006525980A5
Authority
JP
Japan
Prior art keywords
group
ring
forms
carbon atom
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006506051A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006525980A (ja
Filing date
Publication date
Priority claimed from GB0307366A external-priority patent/GB0307366D0/en
Priority claimed from GB0307370A external-priority patent/GB0307370D0/en
Application filed filed Critical
Priority claimed from PCT/GB2004/001367 external-priority patent/WO2004087124A1/en
Publication of JP2006525980A publication Critical patent/JP2006525980A/ja
Publication of JP2006525980A5 publication Critical patent/JP2006525980A5/ja
Withdrawn legal-status Critical Current

Links

JP2006506051A 2003-03-29 2004-03-29 セロトニン5−ht17レセプターアンタゴニスト活性及びムスカリンm4レセプターアゴニスト活性を有する化合物及び精神病の治療でのそれらの使用 Withdrawn JP2006525980A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0307366A GB0307366D0 (en) 2003-03-29 2003-03-29 Compounds
GB0307370A GB0307370D0 (en) 2003-03-29 2003-03-29 Compounds I
PCT/GB2004/001367 WO2004087124A1 (en) 2003-03-29 2004-03-29 Compounds having serotonin 5-ht17 receptor antagonist activity and muscarinic m4 receptor agonist activity and their use in the treatment of psychotic disorders

Publications (2)

Publication Number Publication Date
JP2006525980A JP2006525980A (ja) 2006-11-16
JP2006525980A5 true JP2006525980A5 (https=) 2006-12-28

Family

ID=33133138

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006506051A Withdrawn JP2006525980A (ja) 2003-03-29 2004-03-29 セロトニン5−ht17レセプターアンタゴニスト活性及びムスカリンm4レセプターアゴニスト活性を有する化合物及び精神病の治療でのそれらの使用

Country Status (4)

Country Link
US (1) US20060199978A1 (https=)
EP (1) EP1608354A1 (https=)
JP (1) JP2006525980A (https=)
WO (1) WO2004087124A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130029846A1 (en) 2010-03-29 2013-01-31 Basf Se Fungicidal Iminoderivatives
NO346598B1 (en) 2020-12-23 2022-10-24 Klingelberg Products As Method for the preparation of amidines and amide manufactured by the method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL27999A (en) * 1966-05-25 1971-08-25 Egyt Gyogyszervegyeszeti Gyar Naphthyl-and tetrahydronaphthyl-formamidines
DE2849558A1 (de) * 1978-11-15 1980-05-29 Bayer Ag Substituierte phenyliminomethyl- harnstoffe, verfahren zu ihrer herstellung und ihre verwendung als pflanzenbakterizide
SE9500998D0 (sv) * 1995-03-19 1995-03-19 Haakan Wilhelm Wikstroem New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics
JP2001510797A (ja) * 1997-07-22 2001-08-07 イーライ・リリー・アンド・カンパニー 医薬化合物

Similar Documents

Publication Publication Date Title
JP2006515626A5 (https=)
JP2009535462A5 (https=)
JP2006240292A5 (https=)
JP2010501534A5 (https=)
JP2006520339A5 (https=)
JP2007510619A5 (https=)
JP2007503202A5 (https=)
JP2005053931A5 (https=)
JP2004538039A5 (https=)
JP2010536766A5 (https=)
JP2004535412A5 (https=)
JP2007535595A5 (https=)
JP2007505773A5 (https=)
JP2002332234A5 (https=)
JP2005538089A5 (https=)
JP2007502904A5 (https=)
JP2005511697A5 (https=)
JP2007119504A5 (https=)
JP2007532575A5 (https=)
JP2008540542A5 (https=)
JP2005154436A5 (https=)
JP2008506698A5 (https=)
JP2006525980A5 (https=)
JP2006521440A5 (https=)
JP2005526149A5 (https=)